UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 114

Sortiert nach

COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography

Journal of thrombosis and thrombolysis, 2021-10, Vol.52 (3), p.766-771

2021

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography

Journal of thrombosis and thrombolysis, 2021-10, Vol.52 (3), p.766-771

2021

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Hematocrit on Fibrin Clot Formation Assessed by Rotational Thromboelastometry

Anesthesia and analgesia, 2012-07, Vol.115 (1), p.16-21

2012

Link zum Volltext

Verfügbarkeit prüfen

A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery

Transfusion (Philadelphia, Pa.), 2012-01, Vol.52 (1), p.14-22

2012

Link zum Volltext

Verfügbarkeit prüfen

Differential Contributions of Intrinsic and Extrinsic Pathways to Thrombin Generation in Adult, Maternal and Cord Plasma Samples

PloS one, 2016-05, Vol.11 (5), p.e0154127-e0154127

2016

Link zum Volltext

Verfügbarkeit prüfen

Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion

Transfusion (Philadelphia, Pa.), 2014-01, Vol.54 (1), p.109-118

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation

Thrombosis research, 2008-01, Vol.122 (1), p.117-123

2008

Link zum Volltext

Verfügbarkeit prüfen

Heterozygous antithrombin deficiency improves in vivo haemostasis in factor VIII-deficient mice

Thrombosis and haemostasis, 2010-06, Vol.103 (6), p.1233

2010

Link zum Volltext

Verfügbarkeit prüfen

Improved Clot Formation by Combined Administration of Activated Factor VII (NovoSeven®) and Fibrinogen (Haemocomplettan® P)

Anesthesia and analgesia, 2008-03, Vol.106 (3), p.732-738

2008

Link zum Volltext

Verfügbarkeit prüfen

The Effects of Platelet Count on Clot Retraction and Tissue Plasminogen Activator-Induced Fibrinolysis on Thrombelastography

Anesthesia and analgesia, 2005-06, Vol.100 (6), p.1781-1785

2005

Link zum Volltext

Verfügbarkeit prüfen

Plasma and cerebral spinal fluid tranexamic acid quantitation in cardiopulmonary bypass patients

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011-03, Vol.879 (7), p.553-556

2011

Link zum Volltext

Verfügbarkeit prüfen

Antithrombin Deficiency Increases Thrombin Activity After Prolonged Cardiopulmonary Bypass

Anesthesia and analgesia, 2008-03, Vol.106 (3), p.713-718

2008

Link zum Volltext

Verfügbarkeit prüfen

COVID‐19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid

Journal of thrombosis and haemostasis, 2022-12, Vol.20 (12), p.2909-2920

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical Use of the Activated Partial Thromboplastin Time and Prothrombin Time for Screening

Clinics in laboratory medicine, 2014-09, Vol.34 (3), p.453-477

2014

Link zum Volltext

Verfügbarkeit prüfen

Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin

Anesthesia and analgesia, 2007-10, Vol.105 (4), p.933-939

2007

Link zum Volltext

Verfügbarkeit prüfen

In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition

Thrombosis and haemostasis, 2010-04, Vol.103 (4), p.863

2010

Link zum Volltext

Verfügbarkeit prüfen

Fibrinogen and Hemostasis: A Primary Hemostatic Target for the Management of Acquired Bleeding

Anesthesia and analgesia, 2012-02, Vol.114 (2), p.261-274

2012

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic Use of Factor IX Concentrate in a Jehovah's Witness Patient

The Annals of thoracic surgery, 2009-11, Vol.88 (5), p.1666-1668

2009

Link zum Volltext

Verfügbarkeit prüfen

In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry

Thrombosis and haemostasis, 2009-05, Vol.101 (5), p.827

2009

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Comparative Study of Hemostatic Components in Warfarin-Treated and Fibrinogen-Deficient Plasma

Journal of cardiothoracic and vascular anesthesia, 2010-06, Vol.24 (3), p.408-412

2010

Link zum Volltext

Verfügbarkeit prüfen

Protamine Reversal of Heparin Affects Platelet Aggregation and Activated Clotting Time After Cardiopulmonary Bypass

Anesthesia and analgesia, 1998-10, Vol.87 (4), p.781-785

1998

Link zum Volltext

Verfügbarkeit prüfen

Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing

Clinics in laboratory medicine, 2014-09, Vol.34 (3), p.453

2014

Link zum Volltext

Verfügbarkeit prüfen

Argatroban “Reversal” Is Caused by Nonphysiologic Stimulation of Coagulation, Not Activated Factor VII

Journal of cardiothoracic and vascular anesthesia, 2010-12, Vol.24 (6), p.1026-1027

2010

Link zum Volltext

Verfügbarkeit prüfen

Controlled Multifactorial Coagulopathy: Effects of Dilution, Hypothermia, and Acidosis on Thrombin Generation In Vitro

Anesthesia and analgesia, 2020-04, Vol.130 (4), p.1063-1076

2020

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of nonimmunological histamine and Tryptase release from human cutaneous mast cells

Anesthesiology (Philadelphia), 2000-04, Vol.92 (4), p.1074-1081

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(113)
Berichte
(1)

Sprache

Englisch
(114)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(70)
Life Sciences & Biomedicine
(69)
Humans
(65)
Biological And Medical Sciences
(46)
Medical Sciences
(46)
Anesthesiology
(37)
Female
(26)
Hematology
(24)
Male
(24)
Middle Aged
(22)
Pharmacology. Drug Treatments
(21)
Dose-Response Relationship, Drug
(18)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(17)
Aged
(16)
Anesthesia
(16)
Cardiovascular System & Cardiology
(15)
Thrombin - Metabolism
(15)
Peripheral Vascular Disease
(14)
Recombinant Proteins - Pharmacology
(14)
Thrombelastography
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography

COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography

The Impact of Hematocrit on Fibrin Clot Formation Assessed by Rotational Thromboelastometry

A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery

Differential Contributions of Intrinsic and Extrinsic Pathways to Thrombin Generation in Adult, Maternal and Cord Plasma Samples

Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion

Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation

Heterozygous antithrombin deficiency improves in vivo haemostasis in factor VIII-deficient mice

Improved Clot Formation by Combined Administration of Activated Factor VII (NovoSeven®) and Fibrinogen (Haemocomplettan® P)

The Effects of Platelet Count on Clot Retraction and Tissue Plasminogen Activator-Induced Fibrinolysis on Thrombelastography

Plasma and cerebral spinal fluid tranexamic acid quantitation in cardiopulmonary bypass patients

Antithrombin Deficiency Increases Thrombin Activity After Prolonged Cardiopulmonary Bypass

COVID‐19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid

Clinical Use of the Activated Partial Thromboplastin Time and Prothrombin Time for Screening

Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin

In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition

Fibrinogen and Hemostasis: A Primary Hemostatic Target for the Management of Acquired Bleeding

Prophylactic Use of Factor IX Concentrate in a Jehovah's Witness Patient

In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry

In Vitro Comparative Study of Hemostatic Components in Warfarin-Treated and Fibrinogen-Deficient Plasma

Protamine Reversal of Heparin Affects Platelet Aggregation and Activated Clotting Time After Cardiopulmonary Bypass

Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing

Argatroban “Reversal” Is Caused by Nonphysiologic Stimulation of Coagulation, Not Activated Factor VII

Controlled Multifactorial Coagulopathy: Effects of Dilution, Hypothermia, and Acidosis on Thrombin Generation In Vitro

Mechanisms of nonimmunological histamine and Tryptase release from human cutaneous mast cells

Suchergebnisse filtern